The Shea group investitages antigen-conjugated nanoparticle treatment

The Shea group investigates antigen-conjugated nanoparticle treatment

Posted on 05 Jul

The Shea group investigates antigen-conjugated nanoparticle treatment


« Back to News

The Biointerfaces Institute brings extensive experience to the collaborations that lead to scientific breakthroughs, successful translation, and advanced learning.

Work With Us
a